{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:10:25Z","timestamp":1790266225693,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"FWO","award":["G0C8920N"],"award-info":[{"award-number":["G0C8920N"]}]},{"name":"FWO","award":["G060623N"],"award-info":[{"award-number":["G060623N"]}]},{"name":"FWO","award":["1804123N"],"award-info":[{"award-number":["1804123N"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00467-026-07398-0","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:00:15Z","timestamp":1781330415000},"page":"4073-4081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring urinary allantoin and adenosine in pediatric autosomal dominant polycystic kidney disease: no clear association with disease severity"],"prefix":"10.1007","volume":"41","author":[{"given":"Corinna","family":"Heinze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmin","family":"Andries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Decuypere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Breysem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"De Keyzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Vermeersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Bammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi","family":"Vennekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-6088","authenticated-orcid":false,"given":"Djalila","family":"Mekahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9583-984X","authenticated-orcid":false,"given":"Ann","family":"Van Schepdael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"7398_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/JAMA.2025.0310","volume":"333","author":"FT Chebib","year":"2025","unstructured":"Chebib FT, Hanna C, Harris PC et al (2025) Autosomal dominant polycystic kidney disease: a review. JAMA 333:1708\u20131719. https:\/\/doi.org\/10.1001\/JAMA.2025.0310","journal-title":"JAMA"},{"key":"7398_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le Gall","year":"2017","unstructured":"Cornec-Le Gall E, Torres VE, Harris PC (2017) Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J Am Soc Nephrol 29:13. https:\/\/doi.org\/10.1681\/ASN.2017050483","journal-title":"J Am Soc Nephrol"},{"key":"7398_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/CEOR.S76269","volume":"7","author":"SM Brunelli","year":"2015","unstructured":"Brunelli SM, Blanchette CM, Claxton AJ et al (2015) End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases. Clinicoecon Outcomes Res 7:65\u201372. https:\/\/doi.org\/10.2147\/CEOR.S76269","journal-title":"Clinicoecon Outcomes Res"},{"key":"7398_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/S10157-012-0611-9","volume":"16","author":"E Higashihara","year":"2012","unstructured":"Higashihara E, Horie S, Muto S et al (2012) Renal disease progression in autosomal dominant polycystic kidney disease. Clin Exp Nephrol 16:622\u2013628. https:\/\/doi.org\/10.1007\/S10157-012-0611-9","journal-title":"Clin Exp Nephrol"},{"key":"7398_CR5","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2215\/CJN.01010211","volume":"6","author":"I Helal","year":"2011","unstructured":"Helal I, Reed B, Mcfann K et al (2011) Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6:2439\u20132443. https:\/\/doi.org\/10.2215\/CJN.01010211","journal-title":"Clin J Am Soc Nephrol"},{"key":"7398_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/S00467-016-3364-Y","volume":"32","author":"BV Reddy","year":"2017","unstructured":"Reddy BV, Chapman AB (2017) The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol 32:31\u201342. https:\/\/doi.org\/10.1007\/S00467-016-3364-Y","journal-title":"Pediatr Nephrol"},{"key":"7398_CR7","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/S00467-010-1617-8","volume":"25","author":"D Mekahli","year":"2010","unstructured":"Mekahli D, Woolf AS, Bockenhauer D (2010) Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms. Pediatr Nephrol 25:2275\u20132282. https:\/\/doi.org\/10.1007\/S00467-010-1617-8","journal-title":"Pediatr Nephrol"},{"key":"7398_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/S00467-012-2192-Y","volume":"27","author":"L Selistre","year":"2012","unstructured":"Selistre L, De Souza V, Ranchin B et al (2012) Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease. Pediatr Nephrol 27:1589\u20131593. https:\/\/doi.org\/10.1007\/S00467-012-2192-Y","journal-title":"Pediatr Nephrol"},{"key":"7398_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/NRNEPH.2009.13","volume":"5","author":"T Ecder","year":"2009","unstructured":"Ecder T, Schrier RW (2009) Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 5:221\u2013228. https:\/\/doi.org\/10.1038\/NRNEPH.2009.13","journal-title":"Nat Rev Nephrol"},{"key":"7398_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1053\/J.AJKD.2011.02.379","volume":"57","author":"RW Schrier","year":"2011","unstructured":"Schrier RW (2011) Hypertension and autosomal dominant polycystic kidney disease. Am J Kidney Dis 57:811\u2013813. https:\/\/doi.org\/10.1053\/J.AJKD.2011.02.379","journal-title":"Am J Kidney Dis"},{"key":"7398_CR11","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1046\/J.1523-1755.2003.00236.X","volume":"64","author":"D Wang","year":"2003","unstructured":"Wang D, Iversen J, Wilcox CS, Strandgaard S (2003) Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int 64:1381\u20131388. https:\/\/doi.org\/10.1046\/J.1523-1755.2003.00236.X","journal-title":"Kidney Int"},{"key":"7398_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.DIABRES.2008.12.013","volume":"84","author":"F Grover-P\u00e1ez","year":"2009","unstructured":"Grover-P\u00e1ez F, Zavalza-G\u00f3mez AB (2009) Endothelial dysfunction and cardiovascular risk factors. Diabetes Res Clin Pract 84:1\u201310. https:\/\/doi.org\/10.1016\/J.DIABRES.2008.12.013","journal-title":"Diabetes Res Clin Pract"},{"key":"7398_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1053\/J.AJKD.2007.09.020","volume":"51","author":"D Wang","year":"2008","unstructured":"Wang D, Strandgaard S, Borresen ML et al (2008) Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease. Am J Kidney Dis 51:184\u2013191. https:\/\/doi.org\/10.1053\/J.AJKD.2007.09.020","journal-title":"Am J Kidney Dis"},{"key":"7398_CR14","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1681\/ASN.V1181371","volume":"11","author":"D Wang","year":"2000","unstructured":"Wang D, Iversen J, Strandgaard S (2000) Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11:1371\u20131376. https:\/\/doi.org\/10.1681\/ASN.V1181371","journal-title":"J Am Soc Nephrol"},{"key":"7398_CR15","doi-asserted-by":"publisher","first-page":"F1198","DOI":"10.1152\/AJPRENAL.00327.2014","volume":"307","author":"J Klawitter","year":"2014","unstructured":"Klawitter J, Reed-Gitomer BY, McFann K et al (2014) Endothelial dysfunction and oxidative stress in polycystic kidney disease. Am J Physiol Renal Physiol 307:F1198\u2013F1206. https:\/\/doi.org\/10.1152\/AJPRENAL.00327.2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"7398_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/NDT\/GFW013","volume":"32","author":"KL Nowak","year":"2017","unstructured":"Nowak KL, Farmer H, Cadnapaphornchai MA et al (2017) Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 32:342\u2013347. https:\/\/doi.org\/10.1093\/NDT\/GFW013","journal-title":"Nephrol Dial Transplant"},{"key":"7398_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.13075\/MP.5893.00137","volume":"66","author":"M Czerska","year":"2015","unstructured":"Czerska M, Miko\u0142ajewska K, Zieli\u0144ski M et al (2015) Today\u2019s oxidative stress markers. Med Pr 66:393\u2013405. https:\/\/doi.org\/10.13075\/MP.5893.00137","journal-title":"Med Pr"},{"key":"7398_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/10715769309147501","volume":"18","author":"M Hicks","year":"1993","unstructured":"Hicks M, Wong LS, Day RO (1993) Identification of products from oxidation of uric acid induced by hydroxyl radicals. Free Radic Res Commun 18:337\u2013351. https:\/\/doi.org\/10.3109\/10715769309147501","journal-title":"Free Radic Res Commun"},{"key":"7398_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/J.CCA.2012.06.012","volume":"413","author":"D Il\u2019yasova","year":"2012","unstructured":"Il\u2019yasova D, Scarbrough P, Spasojevic I (2012) Urinary biomarkers of oxidative status. Clin Chim Acta 413:1446. https:\/\/doi.org\/10.1016\/J.CCA.2012.06.012","journal-title":"Clin Chim Acta"},{"key":"7398_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/S11906-020-01116-3","volume":"22","author":"JT Kielstein","year":"2020","unstructured":"Kielstein JT, Pontremoli R, Burnier M (2020) Management of hyperuricemia in patients with chronic kidney disease: a focus on renal protection. Curr Hypertens Rep 22:102. https:\/\/doi.org\/10.1007\/S11906-020-01116-3","journal-title":"Curr Hypertens Rep"},{"key":"7398_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000353730","volume":"123","author":"I Kocyigit","year":"2013","unstructured":"Kocyigit I, Yilmaz MI, Orscelik O et al (2013) Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. Nephron Clin Pract 123:157\u2013164. https:\/\/doi.org\/10.1159\/000353730","journal-title":"Nephron Clin Pract"},{"key":"7398_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/AJPRENAL.00722.2009\/SUPPL_FILE\/SUPPDATA.PDF","volume":"298","author":"SL Taylor","year":"2010","unstructured":"Taylor SL, Ganti S, Bukanov NO et al (2010) A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol Renal Physiol 298:909\u2013922. https:\/\/doi.org\/10.1152\/AJPRENAL.00722.2009\/SUPPL_FILE\/SUPPDATA.PDF","journal-title":"Am J Physiol Renal Physiol"},{"key":"7398_CR23","doi-asserted-by":"publisher","DOI":"10.1152\/AJPRENAL.00262.2021","volume":"322","author":"K Hopp","year":"2022","unstructured":"Hopp K, Kleczko EK, Gitomer BY et al (2022) Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease. Am J Physiol Renal Physiol 322:F258. https:\/\/doi.org\/10.1152\/AJPRENAL.00262.2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"7398_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/J.KINT.2024.07.009","volume":"107","author":"O Devuyst","year":"2025","unstructured":"Devuyst O, Ahn C, Barten TRM et al (2025) KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD). Kidney Int 107:S1\u2013S239. https:\/\/doi.org\/10.1016\/J.KINT.2024.07.009","journal-title":"Kidney Int"},{"key":"7398_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7326\/M20-4366","volume":"174","author":"H Pottel","year":"2021","unstructured":"Pottel H, Bj\u00f6rk J, Courbebaisse M et al (2021) Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate\u202f: a cross-sectional analysis of pooled data. Ann Intern Med 174:183\u2013191. https:\/\/doi.org\/10.7326\/M20-4366","journal-title":"Ann Intern Med"},{"key":"7398_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/S00467-017-3862-6","volume":"33","author":"L Breysem","year":"2018","unstructured":"Breysem L, De Rechter S, De Keyzer F et al (2018) 3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease. Pediatr Nephrol 33:827\u2013835. https:\/\/doi.org\/10.1007\/S00467-017-3862-6","journal-title":"Pediatr Nephrol"},{"key":"7398_CR27","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000122","volume":"18","author":"L Breysem","year":"2023","unstructured":"Breysem L, De Keyzer F, Schellekens P et al (2023) Risk severity model for pediatric autosomal dominant polycystic kidney disease using 3D ultrasound volumetry. Clin J Am Soc Nephrol 18:581. https:\/\/doi.org\/10.2215\/CJN.0000000000000122","journal-title":"Clin J Am Soc Nephrol"},{"key":"7398_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/J.JCHROMB.2018.08.026","volume":"1096","author":"A Andries","year":"2018","unstructured":"Andries A, De Rechter S, Janssens P et al (2018) Simultaneous determination of allantoin and adenosine in human urine using liquid chromatography - UV detection. J Chromatogr B Analyt Technol Biomed Life Sci 1096:201\u2013207. https:\/\/doi.org\/10.1016\/J.JCHROMB.2018.08.026","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"7398_CR29","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1002\/SIM.5515","volume":"31","author":"S Senn","year":"2012","unstructured":"Senn S, Holford N, Hockey H (2012) The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation. Stat Med 31:4280\u20134295. https:\/\/doi.org\/10.1002\/SIM.5515","journal-title":"Stat Med"},{"key":"7398_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Chapman AB, Torres VE (2006) Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 1:148\u2013157. https:\/\/doi.org\/10.2215\/CJN.00330705","journal-title":"Clin J Am Soc Nephrol"},{"key":"7398_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/2054358117693355","volume":"4","author":"N Tangri","year":"2017","unstructured":"Tangri N, Hougen I, Alam A et al (2017) Total kidney volume as a biomarker of disease progression in autosomal dominant polycystic kidney disease. Can J Kidney Health Dis 4:2054358117693355. https:\/\/doi.org\/10.1177\/2054358117693355","journal-title":"Can J Kidney Health Dis"},{"key":"7398_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/01.MBP.0000085762.28312.4A","volume":"8","author":"T Seeman","year":"2003","unstructured":"Seeman T, Du\u0161ek J, Vond\u0159ichov\u00e1 H et al (2003) Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. Blood Press Monit 8:107\u2013110. https:\/\/doi.org\/10.1097\/01.MBP.0000085762.28312.4A","journal-title":"Blood Press Monit"},{"key":"7398_CR33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2215\/CJN.02810608","volume":"4","author":"MA Cadnapaphornchai","year":"2009","unstructured":"Cadnapaphornchai MA, McFann K, Strain JD et al (2009) Prospective change in renal volume and function in children with ADPKD. Clin J Am Soc Nephrol 4:820\u2013829. https:\/\/doi.org\/10.2215\/CJN.02810608","journal-title":"Clin J Am Soc Nephrol"},{"key":"7398_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/J.IJCARD.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, Oppedisano F, Gratteri S et al (2016) Regulation of uric acid metabolism and excretion. Int J Cardiol 213:8\u201314. https:\/\/doi.org\/10.1016\/J.IJCARD.2015.08.109","journal-title":"Int J Cardiol"},{"key":"7398_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/S12975-015-0405-Y","volume":"7","author":"I Esiaba","year":"2016","unstructured":"Esiaba I, Angeles DM, Holden MS et al (2016) Urinary allantoin is elevated in severe intraventricular hemorrhage in the preterm newborn. Transl Stroke Res 7:97\u2013102. https:\/\/doi.org\/10.1007\/S12975-015-0405-Y","journal-title":"Transl Stroke Res"},{"key":"7398_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/03009740510026878","volume":"35","author":"S Yardim-Akaydin","year":"2006","unstructured":"Yardim-Akaydin S, Sepici A, \u00d6zkan Y et al (2006) Evaluation of allantoin levels as a new marker of oxidative stress in Beh\u00e7et\u2019s disease. Scand J Rheumatol 35:61\u201364. https:\/\/doi.org\/10.1080\/03009740510026878","journal-title":"Scand J Rheumatol"},{"key":"7398_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/J.CCA.2013.06.015","volume":"424","author":"WY Chung","year":"2013","unstructured":"Chung WY, Benzie IFF (2013) Plasma allantoin measurement by isocratic liquid chromatography with tandem mass spectrometry: method evaluation and application in oxidative stress biomonitoring. Clin Chim Acta 424:237\u2013244. https:\/\/doi.org\/10.1016\/J.CCA.2013.06.015","journal-title":"Clin Chim Acta"},{"key":"7398_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/J.CCA.2005.09.002","volume":"365","author":"R Kand\u2019\u00e1r","year":"2006","unstructured":"Kand\u2019\u00e1r R, \u017d\u00e1kov\u00e1 P, Mu\u017e\u00e1kov\u00e1 V (2006) Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography. Clin Chim Acta 365:249\u2013256. https:\/\/doi.org\/10.1016\/J.CCA.2005.09.002","journal-title":"Clin Chim Acta"},{"key":"7398_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1021\/ACS.ESTLETT.9B00142","volume":"6","author":"MP Martinez-Moral","year":"2019","unstructured":"Martinez-Moral MP, Kannan K (2019) Allantoin as a marker of oxidative stress: inter- and intraindividual variability in urinary concentrations in healthy individuals. Environ Sci Technol Lett 6:283\u2013288. https:\/\/doi.org\/10.1021\/ACS.ESTLETT.9B00142","journal-title":"Environ Sci Technol Lett"},{"key":"7398_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000013956","volume":"73","author":"T Ogihara","year":"1998","unstructured":"Ogihara T, Kim HS, Hirano K et al (1998) Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease. Biol Neonate 73:24\u201333. https:\/\/doi.org\/10.1159\/000013956","journal-title":"Biol Neonate"},{"key":"7398_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/10715760410001694044","volume":"38","author":"S Yardim-Akaydin","year":"2004","unstructured":"Yardim-Akaydin S, Sepici A, \u00d6zkan Y et al (2004) Oxidation of uric acid in rheumatoid arthritis: is allantoin a marker of oxidative stress? Free Radic Res 38:623\u2013628. https:\/\/doi.org\/10.1080\/10715760410001694044","journal-title":"Free Radic Res"},{"key":"7398_CR42","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/S00726-012-1223-0","volume":"43","author":"A Zinellu","year":"2012","unstructured":"Zinellu A, Sotgia S, Loriga G et al (2012) Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy. Amino Acids 43:1499\u20131507. https:\/\/doi.org\/10.1007\/S00726-012-1223-0","journal-title":"Amino Acids"},{"key":"7398_CR43","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/S00467-018-4004-5","volume":"34","author":"A Andries","year":"2019","unstructured":"Andries A, Daenen K, Jouret F et al (2019) Oxidative stress in autosomal dominant polycystic kidney disease: player and\/or early predictor for disease progression? Pediatr Nephrol 34:993\u20131008. https:\/\/doi.org\/10.1007\/S00467-018-4004-5","journal-title":"Pediatr Nephrol"},{"key":"7398_CR44","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41581-024-00872-8","volume":"20","author":"MGE Knol","year":"2024","unstructured":"Knol MGE, Wulfmeyer VC, M\u00fcller RU, Rinschen MM (2024) Amino acid metabolism in kidney health and disease. Nat Rev Nephrol 20:771\u2013788. https:\/\/doi.org\/10.1038\/s41581-024-00872-8","journal-title":"Nat Rev Nephrol"},{"key":"7398_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.33549\/physiolres.932696","volume":"63","author":"R Kan\u010f\u00e1r","year":"2014","unstructured":"Kan\u010f\u00e1r R, \u0160tramov\u00e1 X, Dr\u00e1bkov\u00e1 P, K\u0159enkov\u00e1 J (2014) A monitoring of allantoin, uric acid, and malondialdehyde levels in plasma and erythrocytes after ten minutes of running activity. Physiol Res 63:753\u2013762. https:\/\/doi.org\/10.33549\/physiolres.932696","journal-title":"Physiol Res"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07398-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:34:35Z","timestamp":1790264075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07398-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["7398"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07398-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study approval was obtained from the ethics committees of the University Hospitals Leuven (approval number S59500).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients, healthy volunteers and their parents gave written, informed consent.","order":2,"name":"Ethics","label":"Consent to participate\/consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}